Ct-ifp Robot
Ct-ifp Robot - Related Videos
04:19
Robotic Enucleation of Esophageal Leiomyoma
0 Views •
2026
This manuscript describes the surgical technique for robotic enucleation of an esophageal leiomyoma, serving as a reference for similar cases.
03:34
Spatial Measurement of Tumor Interstitial Fluid Pressure: A Method to Measure the Interstitial Fluid Pressure
0 Views •
2023
This video describes a technique of measuring the interstitial fluid pressure within a tumor by perfusion imaging using an image-guided robotic system. Measurements are compared to the intra-tumoral accumulation of liposomes, within a solid tumor.
09:00
Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
0 Views •
Cited by 6 •
2016
The heterogeneous intra-tumoral accumulation of liposomes has been linked to an abnormal tumor microenvironment. Herein methods are presented to measure tumor microcirculation by perfusion imaging and elevated interstitial fluid pressure (IFP) using an image-guided robotic system. Measurements are compared to the intra-tumoral accumulation of liposomes, determined using volumetric micro-CT imaging.
08:34
Robot-assisted Partial Splenectomy
0 Views •
2026
This protocol describes a robot-assisted partial splenectomy for a benign splenic tumor. The robotic approach optimizes spleen preservation by enhancing surgical precision, minimizing blood loss, and improving postoperative outcomes. Key surgical steps include meticulous splenic hilum dissection, selective vascular ligation, intraoperative ultrasonography, and controlled parenchymal transection.
11:21
Robotic Ablation of Atrial Fibrillation
0 Views •
Cited by 12 •
2015
Pulmonary vein isolation (PVI) with an ablation catheter is a curative treatment for atrial fibrillation (AF). Robotic catheter systems aim to improve catheter steerability. Here, a procedure with a new robotic catheter system is presented. The goal of the procedure is electrical block between pulmonary vein and left atrium.
FAQs
Elevated or abnormal interstitial fluid pressure can indicate a tumor microenvironment that affects fluid movement through the tissue. Measuring this property helps researchers examine how impaired perfusion may limit therapeutic distribution and contribute to treatment resistance. The resulting pressure data connect a physical tumor characteristic with biological and treatment-related behavior in cancer studies.
Computed tomography guidance allows the operator to select a particular tumor region before the pressure-sensing needle is positioned. The recorded value is then linked to that corresponding anatomical location rather than treated as an undifferentiated measurement for the entire tumor. This spatial association helps reveal regional differences within abnormal tumor microenvironments.
Controlled conditions make measurements more consistent across tumor regions and experimental assessments. By positioning the sensing needle deliberately and recording pressure under a defined setup, the system supports improved precision and reproducibility. These qualities are important when researchers compare pressure patterns, evaluate tumor microenvironment changes, or relate measurements to drug-delivery behavior.
Pressure may vary between locations within the same tumor, so region-specific measurements can expose heterogeneity that a single overall value could obscure. With anatomical location retained, researchers can investigate whether particular areas are associated with impaired perfusion or reduced drug penetration. This supports more detailed analysis of why treatment responses differ across tumor tissue.
The workflow begins by using computed tomography to identify and select a region of interest within a solid tumor. The robot then positions a pressure-sensing needle at that location, records interstitial fluid pressure under controlled conditions, and associates the measurement with the imaged anatomy. This sequence produces a spatially referenced pressure assessment for subsequent cancer research analysis.
Researchers can use the approach in preclinical cancer studies that examine tumor microenvironments, therapeutic delivery, or treatment resistance. Its value is greatest when pressure must be measured accurately at defined tumor locations and compared across regions or experimental conditions. The resulting information may help evaluate strategies intended to improve drug penetration and therapeutic effectiveness.